
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 53.50 | 53.00 | 54.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.45M | -2.64M | -0.1104 | -4.85 | 12.81M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/5/2024 07:15 | Following various fundraisings and strategic changes to the Wanda business as detailed below, the NetScientific Directors believe that the Wanda business has now been materially de-risked, having made significant commercial and operational progress, underpinning significant growth prospects, placing it in a stronger position than in 2019. The Board is accordingly delighted for the Group to be in a position to re-acquire a strategic stake in Wanda, providing it with exposure to the fast-growing remote patient monitoring market. The Investment is in line with the Company's strategy of deepening stakes in selected portfolio companies with high return potential. | ![]() blakieboy7 | |
28/5/2024 07:05 | Another decent deal for NSCI. Wanda on the books as 90% CUA valued at £3.6M. We have no direct holding. We now have 30% direct holding so worth £1M+ (see above) £150K upfront fee. £100K a year management charge. (£8K month) | ![]() loafofbread | |
24/5/2024 08:58 | When this share goes down on light volume it is mainly to do with MM's widening spread to 4 p. When it goes up the spread becomes tighter at 2p or less. You can say that there is actually no movement. | ![]() kingston78 | |
21/5/2024 07:15 | Interesting tweet/X out last night from Netscientific. Charles Swindell is presenting at the Jefferies Health Care on June 4-6th, talking about Glycotest and ProAxis. He runs Glycotest and he hasn't said or done anything for at least 5 years. Is it safe to assume we will have some positive Glycotest news beforehand otherwise he won't have much to say other than talk about 4 years of delays!? | ![]() loafofbread | |
17/5/2024 12:29 | Finally, a nice move up on the bid. | ![]() loafofbread | |
17/5/2024 12:25 | That's better, now let's crack 70p and beyond | ![]() blakieboy7 | |
16/5/2024 16:42 | 70,000 of straight buys today. That first 15k moved the offer up. Interest slowly returning. | ![]() loafofbread | |
16/5/2024 13:38 | In PDSB's 1Q 10-Q report, filed yesterday, you can see that they used their "at the market" sales agreement to sell 3.4m shares into the market at an average price of something like $5.70/share in 1Q. They raised $19.5m this way, which is great for their cash runway, but obviously acts as a headwind for the shareprice. "During the quarter ended March 31, 2024 and 2023, the Company sold 3,428,681 and 553,293 shares of common stock for a net value of $19.5 and $4.6 million, respectively, pursuant to the Sales Agreement." free stock charts from uk.advfn.com | ![]() 1gw | |
16/5/2024 11:51 | I hope that Fosan will bid for the whole of Glycotest. That will be a quantum leap for NSCI. | ![]() kingston78 | |
16/5/2024 09:31 | The MMs do love their delayed trades in NSCI! | ![]() loafofbread | |
15/5/2024 18:32 | NAV is £44M vs £15M MCap I think the risk/reward is as good as it gets. Glycotest is valued in the books at £11M and we are finally close to a read out. Could be worth £5M or £50M if the test works and Fosan want full control. ProAxis worth £8M. since then received another £500K in funding grants. Might go for £10M/£15M with a fair wind. Downside fully protected but upside is potentially massive. | ![]() loafofbread | |
14/5/2024 12:21 | Vox interview much better than yesterdays Proactive effort. Clear explanation of what's to come and how this is a win win for NSCI shareholders. | ![]() loafofbread | |
14/5/2024 09:49 | So much going on but nothing being reflected in the share price! | ![]() blakieboy7 | |
14/5/2024 09:31 | NetScientific Q&A: "we're right in the middle of the action of venture capital" | ![]() sev22 | |
13/5/2024 21:13 | hTtps://stkt.co/Z4P0 | ![]() blakieboy7 | |
13/5/2024 19:37 | Today's news was hugely significant I suspect we will kick on from here in my opinion | ![]() senttothegallows | |
13/5/2024 18:49 | Could also do with some Simon Thompson PR | ![]() blakieboy7 | |
13/5/2024 10:35 | great points. think results are due imminently - perhaps there'll be some positive narrative to expand on the recent raft of good news which stirs up the wider markets. | ![]() mortimer7 | |
13/5/2024 10:18 | Yet again completely ignored by the wider market. M7, I think the ProAxis value uplift from £3.5M to £8M+ might have had you opening that drawer a few weeks ago. They won another £500K grant last week. The sooner the company starts a share buy back to narrow the discount to NAV the better. Once they have closed the gap somewhat they can invest elsewhere! | ![]() loafofbread |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions